Solara Active Pharma Sciences is a dynamic, entrepreneurial and customer-oriented API manufacturer. It has a legacy of over three decades and trace its origins to the API expertise of Strides Shasun Ltd. and the technical know-how of human API business from Sequent Scientific Ltd.

The company is poised to bridge the industry gap by delivering value-based products while maintaining focus on customer needs. It has hundreds of scientists working at its two R&D Centers and many API manufacturing facilities armed with global approvals and 2 dedicated R&D facilities.

The company has a highly compliant manufacturing footprint spread over six large scale multi-product facilities. The company’s business is spread across several countries with extensive operations in the key markets of North America, Europe, Japan, South Korea and the Middle East and North Africa.

Business area of the company

The company is a global, R&D focused, pureplay API company engaged in the manufacturing and development of APIs and offering Contract Manufacturing and Development Services for global companies.

Products and services

Commercial and R&D products
Contract research and Manufacturing

Market Cap	1,242 Cr	ROE	-3.8%
P/E Ratio(TTM)	0.0	EPS(TTM)	0.0
P/B Ratio	0.8	Dividend Yield	0.0%
Industry P/E	65.5	Book Value	416.4
		Face Value	10.0

Fundamentals